Alexandre Jagerschmidt

Dupilumab Efficacy in Patients with Uncontrolled, Moderate-to-Severe Allergic Asthma

Jonathan Corren, Mario Castro, Thomas G. O’Riordan et al. · The Journal of Allergy and Clinical Immunology In Practice · 2019 · 196 citations · Full text

Lysophosphatidic Acid Receptor 1 Antagonist SAR100842 for Patients With Diffuse Cutaneous Systemic Sclerosis

Yannick Allanore, Oliver Distler, Alexandre Jagerschmidt et al. · Arthritis & Rheumatology · 2017 · 106 citations · Full text

Efficacy of dupilumab on clinical outcomes in patients with asthma and perennial allergic rhinitis

William W. Busse, Jorge Máspero, Yufang Lü et al. · Annals of Allergy Asthma & Immunology · 2020 · 78 citations · Full text

Dupilumab Efficacy in Uncontrolled, Moderate-to-Severe Asthma with Self-Reported Chronic Rhinosinusitis

Jorge Máspero, Constance H. Katelaris, William W. Busse et al. · The Journal of Allergy and Clinical Immunology In Practice · 2019 · 69 citations · Full text

Mutation of Asp100 in the second transmembrane domain of the cholecystokinin B receptor increases antagonist binding and reduces signal transduction.

Alexandre Jagerschmidt, N Guillaume, Nathalie Goudreau et al. · Molecular Pharmacology · 1995 · 37 citations